biguanides has been researched along with paclitaxel in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, J; Chen, Y; Gao, X; Huang, Y; Jiang, T; Wang, J; Xiao, W; Xie, L; Zhou, S | 1 |
1 other study(ies) available for biguanides and paclitaxel
| Article | Year |
|---|---|
Biguanide-anchored albumin-based nanoplatform inhibits epithelial-mesenchymal transition and reduces the stemness phenotype for metastatic cancer therapy.
Topics: Albumin-Bound Paclitaxel; Albumins; Animals; Biguanides; Cell Line, Tumor; Epithelial-Mesenchymal Transition; Humans; Nanoparticles; Neoplasms; Paclitaxel | 2023 |